AI assistant
Sending…
DEXCOM INC — Director's Dealing 2018
May 17, 2018
30198_dirs_2018-05-16_a3aaad80-f3ff-46ba-941f-1f910f02aa35.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2018-05-14
Reporting Person: SKYLER JAY S (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-05-14 | Common Stock | M | 30000 | $4.58 | Acquired | 52257 | Indirect |
| 2018-05-14 | Common Stock | S | 30000 | $88.0 | Disposed | 22257 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-05-14 | Non-Qualified Stock Option (right to buy) | $4.58 | M | 30000 | Disposed | 2019-05-19 | Common Stock (30000) | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 4553 | Direct |
| Common Stock | 10000 | Indirect |
Footnotes
F1: Shares are held by Skyler Bach Family Limited Partnership, LLP, with respect to which the reporting person is a managing partner of the partnership and maintains voting rights of these shares.
F2: The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
More from DEXCOM INC
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 15
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 17